Rhew K, Fiedler D A, Ludlow C L
Voice and Speech Section, National Institute on Deafness and Other Communication Disorders, Bethesda, MD 20892.
Otolaryngol Head Neck Surg. 1994 Dec;111(6):787-94. doi: 10.1177/019459989411100615.
A new endoscopic method of injecting botulinum toxin into the thyroarytenoid muscles for treatment of adductor spasmodic dysphonia was evaluated. Twelve patients with adductor spasmodic dysphonia were given injections in the thyroarytenoid muscle under video visualization with a flexible catheter needle that was passed through the working channel of a flexible nasolaryngoscope. Six patients received unilateral injections, and six received bilateral injections. Preinjection and postinjection speech samples were compared by use of spectrographic analysis. Significant decreases in voice breaks and sentence duration were found after treatment with both unilateral and bilateral injections. Patient interviews and diaries documented the reported degree and duration of symptom reduction. All 12 patients reported that the injections were of significant benefit and that the endoscopic procedure was tolerable. We concluded that this is a safe and effective technique for injecting botulinium toxin into laryngeal muscles for treatment of spasmodic dysphonia.
一种用于治疗内收型痉挛性发声障碍的向甲杓肌注射肉毒杆菌毒素的新内镜方法得到了评估。12例内收型痉挛性发声障碍患者在视频可视化下,通过一根可弯曲的导管针经可弯曲鼻咽喉镜的工作通道向甲杓肌注射。6例患者接受单侧注射,6例接受双侧注射。通过频谱分析比较注射前和注射后的语音样本。单侧和双侧注射治疗后,声断和句子时长均显著降低。患者访谈和日记记录了所报告的症状减轻程度和持续时间。所有12例患者均报告注射有显著益处,且内镜操作是可耐受的。我们得出结论,这是一种向喉部肌肉注射肉毒杆菌毒素治疗痉挛性发声障碍的安全有效的技术。